Most AI conversations are still centered on LLMs. GenBio AI Co-Founder & Chief Scientist @ericxing is already three steps ahead. @ben_guggenheim @washingtonpost just sat down with him to break down why LLMs are "book smart" and how GenBio AI's world model can simulate an entire cell, run virtual drug trials, and potentially compress decades of drug discovery into a computational prompt. Full interview 👇 washingtonpost.com/wp-intelligenc…